pneumococcal heptavalent conjugate vaccine, a preparation of capsular polysaccharides from the seven serotypes of Streptococcus pneumoniae most commonly isolated from children 6 years of age or younger coupled with a nontoxic variant of diphtheria toxin, used as an active immunizing agent for infants and children at risk for pneumococcal disease. It is administered intramuscularly.
